DEXTROSE, UNSPECIFIED FORM

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
180.0 -3.2 5 6 110.0 1 1.0
UNII
IY9XDZ35W2
SYNONYMS
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
An,cnblk Intrathecal Injection 7.5%
Im - Iv Injection 5%
Im - Iv Powder, For Injection Solution 3.08%
Im - Iv - Sc Injection
Interstitial Injection
Intracavitary Injection
Intramuscular Injection 4.4%
Intraperitoneal Injection
Intrapleural Injection
Intraspinal Injection 5%
Intravenous Injectable 5%
Intravenous Injection
Intravenous Injection, Solution 5%
Intravenous Powder, For Injection Solution 5.02%
Intravenous Solution 0.05%
Intravenous Solution, Injection 63.13%
Iv(infusion) Injection 4.1%W/V
Iv(infusion) Powder, For Injection Solution 3.08%
Iv(infusion) Powder, For Injection Solution 5%
Nasal Spray, Metered 5%
Oral Concentrate
Oral Concentrate 40%
Oral Granule, For Oral Suspension 2813MG
Oral Liquid
Oral Pastille 157MG
Oral Pastille 826MG
Oral Pellet 2813MG
Oral Powder, For Solution
Oral Solution 49.78%
Oral Solution, Elixir
Oral Suspension
Oral Syrup 27%
Oral Syrup
Oral Tablet 183.66MG
Oral Tablet 10.37MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 398MG
Oral Tablet, Extended Release 103.95MG
Oral Tablet, Sustained Action 2MG
Oral Tablet, Uncoated, Troche 903.5MG
Oral Tablet, Uncoated, Troche
Spinal Injection 7.5%
Sublingual Tablet 115.78MG

More Information

Usage Over Time

Comments